Living With MTLE-HS and Long-Term Outlook
At a Glance
For people with mesial temporal lobe epilepsy and hippocampal sclerosis, long-term wellbeing depends on seizure control, taking medicines as prescribed, regular sleep, safety planning, and specialist follow-up. Memory, driving, SUDEP risk, and medication changes should be reviewed with your care team.
Living with Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis (MTLE-HS) is a marathon, not a sprint. While the diagnosis brings challenges, many people find that with the right combination of treatment and lifestyle adjustments, they can lead full, active lives. The long-term goal is not just “fewer seizures,” but protecting your brain health and maximizing your quality of life [1][2].
Cognition and Memory Over Time
Because the hippocampus is central to memory, MTLE-HS can affect how you process and store information.
- The Burden of Seizures: Research suggests that frequent, uncontrolled seizures—especially those that start early in life—can be associated with decline in memory and word-finding skills [3]. This is one reason why experts emphasize finding an effective treatment early. However, cognitive problems can also reflect medications, sleep, or mood, and decline is not inevitable.
- The ‘Network’ Effect: Cognitive changes aren’t always just about the seizures themselves; they can be influenced by the “network” of the brain, your mood, and sometimes the side effects of medications like lethargy or “brain fog” [4][5].
- Surgical Impact: If you choose surgery, there is a recognized risk of specific memory changes, particularly verbal memory if the surgery is on your “dominant” side (usually the left) [6][7]. However, for many, the trade-off—stopping seizures and eventually reducing medications—leads to an overall improvement in quality of life [1].
Driving and Independence
Driving is one of the most significant lifestyle concerns for adults with epilepsy. Do not drive until legally permitted and medically advised.
- Legal Requirements: Driving laws vary by state and country, but they almost always require a “seizure-free interval” (often 3 to 12 months) before you can return to the road [8]. Check with your local licensing authority.
- Auras vs. Blackouts: Doctors must carefully distinguish between seizures where you lose awareness and “auras” (focal aware seizures). While some jurisdictions are stricter than others, any event that could impair your ability to react safely typically resets your driving clock [9][8].
- Medication Changes: If you and your doctor decide to reduce or stop your medication after years of being seizure-free, you must be aware that the risk of a breakthrough seizure is highest in the first two years after the change [10]. This may require a temporary pause in driving.
Seizure First Aid & Emergency Planning
It is critical that family and coworkers know what to do. If you have a seizure: stay with the person, time the seizure, protect their head, and turn them on their side after convulsions. Do not restrain them and never put anything in their mouth. Seek emergency help for a seizure lasting five minutes or more, repeated seizures without recovery, breathing difficulty, or injury.
Understanding and Reducing SUDEP Risk
SUDEP stands for Sudden Unexpected Death in Epilepsy. While it is rare, it is a serious topic that is important to understand so you can take steps to protect yourself.
- The Major Risk Factors: The greatest risk for SUDEP is having uncontrolled focal-to-bilateral tonic-clonic seizures (convulsions), especially if they occur frequently or during the night [11][12].
- The Best Prevention: The single most effective way to lower your risk is to achieve the best possible seizure control [13]. This means:
- Strict Adherence: Taking your medication exactly as prescribed every single day [14].
- Following the Plan: If your current meds aren’t working, moving forward with an evaluation at a specialized center [11].
- Nighttime Safety: For some, using seizure-detection devices or having someone else in the home can provide an extra layer of safety, though these tools are a supplement to, not a replacement for, medical treatment, and they have not been medically proven to prevent SUDEP [15][16].
Practical Lifestyle Adjustments
A healthy brain network is less likely to seize. Prioritize a regular sleep schedule, as sleep deprivation is a major seizure trigger. Be aware that alcohol and recreational drugs can lower your seizure threshold and interact dangerously with medications. For personal safety, never bathe or swim alone, and avoid climbing heights where a sudden loss of awareness could lead to a fall.
The Path Forward
Success in MTLE-HS is defined by more than just a clear EEG. It includes your ability to work, your mood, and your sense of connection to others. People who achieve seizure freedom—whether through medication or surgery—often see dramatic improvements in their mood and a reduction in the “stigma” they feel [2][17]. By staying engaged with your specialized care team and being an active participant in your treatment decisions, you can take control of your long-term prognosis.
Common questions in this guide
Can MTLE-HS cause memory and word-finding problems over time?
How long must I be seizure-free before driving again with MTLE-HS?
What can I do to lower my SUDEP risk?
What should my family do during a seizure?
Is it safe to stop epilepsy medicine after years without seizures?
What daily habits can make living with MTLE-HS safer?
Could epilepsy surgery affect my memory?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Mesial temporal lobe epilepsy with hippocampal sclerosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What are the specific driving laws in my state for focal seizures versus 'auras' where I stay fully aware?
- 2.Based on my current seizure types, what is my individual risk for SUDEP, and what are the most effective steps I can take to minimize it?
- 3.How often should I have repeat neuropsychological testing to monitor my memory and word-finding skills over the long term?
- 4.If I become seizure-free for several years, what are the risks and benefits of trying to reduce or stop my medications?
- 5.Are there specific seizure-detection devices or nocturnal monitoring tools you recommend for my situation?
References
References (17)
- 1
Resective epilepsy surgery for drug-resistant focal epilepsy: a review.
Jobst BC, Cascino GD
JAMA 2015; (313(3)):285-93 doi:10.1001/jama.2014.17426.
PMID: 25602999 - 2
Predictors of meaningful improvement in quality of life after temporal lobe epilepsy surgery: A prospective study.
Pauli C, Schwarzbold ML, Diaz AP, et al.
Epilepsia 2017; (58(5)):755-763 doi:10.1111/epi.13721.
PMID: 28332703 - 3
Review: Neurodegenerative processes in temporal lobe epilepsy with hippocampal sclerosis: Clinical, pathological and neuroimaging evidence.
Tai XY, Bernhardt B, Thom M, et al.
Neuropathology and applied neurobiology 2018; (44(1)):70-90 doi:10.1111/nan.12458.
PMID: 29288503 - 4
Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.
Androsova G, Krause R, Borghei M, et al.
Epilepsia 2017; (58(10)):1734-1741 doi:10.1111/epi.13871.
PMID: 28857179 - 5
Is self-report sleepiness associated with cognitive performance in temporal lobe epilepsy?
Vascouto HD, Thais MERO, Osório CM, et al.
Arquivos de neuro-psiquiatria 2018; (76(9)):575-581 doi:10.1590/0004-282X20180089.
PMID: 30365619 - 6
Neuropsychologist's (re-)view: Resective versus ablative amygdalohippocampectomies.
Witt JA, Hoppe C, Helmstaedter C
Epilepsy research 2018; (142()):161-166 doi:10.1016/j.eplepsyres.2017.08.017.
PMID: 28890320 - 7
Comparison of minimally invasive to standard temporal lobectomy approaches to epilepsy surgery: Seizure relief and visual confrontation naming outcomes.
Hageboutros K, Hewitt KC, Lee GP, et al.
Epilepsy & behavior : E&B 2024; (155()):109669 doi:10.1016/j.yebeh.2024.109669.
PMID: 38663142 - 8
Auras and the risk of seizures with impaired consciousness following epilepsy surgery: implications for driving.
Fairclough S, O'Keeffe AG, de Tisi J, Duncan JS
Journal of neurology, neurosurgery, and psychiatry 2018; (89(6)):599-602 doi:10.1136/jnnp-2017-316578.
PMID: 29223975 - 9
Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy.
Beniczky S, Trinka E, Wirrell E, et al.
Epilepsia 2025; (66(6)):1804-1823 doi:10.1111/epi.18338.
PMID: 40264351 - 10
Risk of seizure relapse after antiepileptic drug withdrawal in adult patients with focal epilepsy.
He RQ, Zeng QY, Zhu P, et al.
Epilepsy & behavior : E&B 2016; (64(Pt A)):233-238 doi:10.1016/j.yebeh.2016.08.006.
PMID: 27764734 - 11
Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Harden C, Tomson T, Gloss D, et al.
Epilepsy currents 2017; (17(3)):180-187 doi:10.5698/1535-7511.17.3.180.
PMID: 28684957 - 12
Association of sleep with sudden unexpected death in epilepsy.
Ali A, Wu S, Issa NP, et al.
Epilepsy & behavior : E&B 2017; (76()):1-6 doi:10.1016/j.yebeh.2017.08.021.
PMID: 28917499 - 13
From unwitnessed fatality to witnessed rescue: Nonpharmacologic interventions in sudden unexpected death in epilepsy.
Rugg-Gunn F, Duncan J, Hjalgrim H, et al.
Epilepsia 2016; (57 Suppl 1()):26-34 doi:10.1111/epi.13231.
PMID: 26749014 - 14
Pharmacologic treatment and SUDEP risk: A nationwide, population-based, case-control study.
Sveinsson O, Andersson T, Mattsson P, et al.
Neurology 2020; (95(18)):e2509-e2518 doi:10.1212/WNL.0000000000010874.
PMID: 32967928 - 15
Can We Prevent Sudden Unexpected Death in Epilepsy (SUDEP)?
Bhasin H, Sharma S, Ramachandrannair R
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2021; (48(4)):464-468 doi:10.1017/cjn.2020.221.
PMID: 33023683 - 16
Antiseizure Medications and Sudden Unexpected Death in Epilepsy: An Updated Review.
Bosch AT, Sander JW, Thijs RD
CNS drugs 2024; (38(10)):807-817 doi:10.1007/s40263-024-01112-0.
PMID: 39112912 - 17
Social impairment and stigma in genetic generalized epilepsies.
Gabriel D, Ventura M, Samões R, et al.
Epilepsy & behavior : E&B 2020; (104(Pt A)):106886 doi:10.1016/j.yebeh.2019.106886.
PMID: 31931462
This page is for informational purposes only and does not constitute medical advice. Your neurologist or epilepsy care team can advise you about driving, medication changes, SUDEP risk, and safety planning.